Compare · CNSP vs SBFM

CNSP vs SBFM

Side-by-side comparison of CNS Pharmaceuticals Inc. (CNSP) and Sunshine Biopharma Inc. (SBFM): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both CNSP and SBFM operate in Biotechnology: Pharmaceutical Preparations (Health Care), so they compete in similar markets.
  • CNSP is the larger of the two at $5.8M, about 3.0x SBFM ($1.9M).
  • SBFM has been more active in the news (6 items in the past 4 weeks vs 2 for CNSP).
MetricCNSPSBFM
Company
CNS Pharmaceuticals Inc.
Sunshine Biopharma Inc.
Price
-
-
Market cap
$5.8M
$1.9M
1M return
-
-45.57%
1Y return
-
-99.11%
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Exchange
NASDAQ
NASDAQ
IPO
2019
News (4w)
2
6
Recent ratings
0
0
CNSP

CNS Pharmaceuticals Inc.

CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, which completed Phase I clinical trial that is used for the treatment of glioblastoma multiforme. It has license agreements with Houston Pharmaceuticals, Inc. and The University of Texas M.D. Anderson Cancer Center; and a development agreement with WPD Pharmaceuticals Inc. The company was founded in 2017 and is based in Houston, Texas.

SBFM

Sunshine Biopharma Inc.

Sunshine Biopharma, Inc., a pharmaceutical and nutritional supplement company, focuses on the research and development of anticancer drugs. The company is developing Adva-27a, a GEM-difluorinated C-glycoside derivative of podophyllotoxin to treat leukemia, lymphoma, testicular, lung, brain, prostate, bladder, colon, ovarian, liver, and other forms of cancers, as well as kills multidrug resistant cancer cells, including pancreatic cancer, breast cancer, small-cell lung cancer, and uterine sarcoma cells; and SBFM-PL4, an anti-coronavirus treatment compound. It also offers Essential 9, a nutritional supplement tablet; and Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name, as well as develops and markets other science-based nutritional supplements. The company has a license agreement with the University of Georgia to advance the development of its anti-coronavirus lead compound, SBFM-PL4. Sunshine Biopharma, Inc. is headquartered in Pointe-Claire, Canada.